The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Insulin (fasting)
The Ulta Wellness - Diabetes Health Screening panel contains 3 tests with 23 biomarkers.
Brief Description:
The Ulta Wellness - Diabetes Health Screening is a targeted diagnostic tool designed to evaluate key factors related to diabetes and pre-diabetes conditions. This screening encompasses a Comprehensive Metabolic Panel (CMP), Hemoglobin A1c (HbA1c), and Insulin tests. These tests collectively provide a snapshot of an individual's glucose metabolism, insulin function, and overall metabolic health, essential for diagnosing diabetes and managing those at risk.
Collection Method: Blood Draw
Specimen Type: Whole Blood and Serum
Test Preparation: 9 Hours Fasting Required
This screening may be ordered for individuals showing symptoms of diabetes, such as excessive thirst, frequent urination, fatigue, and blurred vision. It is also recommended for those with risk factors for developing diabetes, including obesity, high blood pressure, family history of diabetes, and certain ethnic backgrounds. Regular screening helps in early detection and management of diabetes, allowing for timely intervention to prevent or delay the onset of complications associated with the disease.
Comprehensive Metabolic Panel (CMP)
The CMP is a broad screening tool that measures various substances in the blood, providing information about the health of the kidneys, liver, and electrolyte and acid/base balance, as well as blood sugar (glucose) levels. This test helps identify conditions that may accompany or contribute to diabetes.
HbA1c measures the average blood glucose concentration over the past two to three months. It reflects how well blood glucose levels are being managed over a longer term. High levels indicate poorer control of blood glucose and can diagnose pre-diabetes and diabetes.
This test measures the amount of insulin, the hormone responsible for allowing glucose in the blood to enter cells. High levels can indicate insulin resistance, a condition where the body's cells don't respond properly to insulin, often preceding the development of type 2 diabetes.
Diabetes Mellitus
Diabetes mellitus is a chronic condition characterized by high levels of glucose in the blood, either due to insufficient insulin production (type 1 diabetes) or insulin resistance (type 2 diabetes). The HbA1c test is a key marker for diagnosing diabetes, while the insulin test can help determine insulin resistance in type 2 diabetes. The CMP can reveal elevated blood glucose levels and provide insights into complications affecting the liver and kidneys.
Pre-diabetes
Pre-diabetes is a condition where blood glucose levels are higher than normal but not high enough for a diabetes diagnosis. It indicates a high risk of developing type 2 diabetes. Elevated HbA1c and possibly insulin levels in the screening can detect pre-diabetes, enabling interventions to prevent the progression to diabetes.
Diabetes Mellitus
For diagnosed diabetes, healthcare professionals use the screening results to tailor treatment strategies, including medication, diet, and lifestyle changes. Regular HbA1c testing monitors the effectiveness of management strategies in maintaining target blood glucose levels. The CMP and insulin tests aid in adjusting treatment plans and identifying metabolic complications early.
Pre-diabetes
In cases of pre-diabetes, elevated HbA1c and insulin levels prompt interventions focused on lifestyle modifications, such as diet and exercise, to lower the risk of developing type 2 diabetes. Regular follow-up screenings track progress and efficacy of preventive measures.
The Ulta Wellness - Diabetes Health Screening is a crucial diagnostic and monitoring tool for individuals at risk of or currently managing diabetes. By evaluating glucose control, insulin function, and overall metabolic health, this comprehensive screening provides valuable insights that guide effective treatment and preventive strategies. Regular use of this screening can facilitate early detection of diabetes and pre-diabetes, enable timely intervention, and help individuals achieve better health outcomes by managing or even preventing the development of diabetes and its associated complications.